Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Obesity, leptin resistance, and the effects of insulin reduction.
Lustig RH, Sen S, Soberman JE, Velasquez-Mieyer PA. Lustig RH, et al. Among authors: velasquez mieyer pa. Int J Obes Relat Metab Disord. 2004 Oct;28(10):1344-8. doi: 10.1038/sj.ijo.0802753. Int J Obes Relat Metab Disord. 2004. PMID: 15314628 Clinical Trial.
Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults.
Velasquez-Mieyer PA, Umpierrez GE, Lustig RH, Cashion AK, Cowan PA, Christensen M, Spencer KA, Burghen GA. Velasquez-Mieyer PA, et al. Int J Obes Relat Metab Disord. 2004 Feb;28(2):330-3. doi: 10.1038/sj.ijo.0802561. Int J Obes Relat Metab Disord. 2004. PMID: 14708034 Free PMC article. Clinical Trial.
Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults.
Velasquez-Mieyer PA, Cowan PA, Arheart KL, Buffington CK, Spencer KA, Connelly BE, Cowan GW, Lustig RH. Velasquez-Mieyer PA, et al. Int J Obes Relat Metab Disord. 2003 Feb;27(2):219-26. doi: 10.1038/sj.ijo.802227. Int J Obes Relat Metab Disord. 2003. PMID: 12587002 Free PMC article. Clinical Trial.
Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects.
Velasquez-Mieyer PA, Cowan PA, Umpierrez GE, Lustig RH, Cashion AK, Burghen GA. Velasquez-Mieyer PA, et al. Int J Obes Relat Metab Disord. 2003 Nov;27(11):1359-64. doi: 10.1038/sj.ijo.0802415. Int J Obes Relat Metab Disord. 2003. PMID: 14574347 Free PMC article.
Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children.
Lustig RH, Mietus-Snyder ML, Bacchetti P, Lazar AA, Velasquez-Mieyer PA, Christensen ML. Lustig RH, et al. Among authors: velasquez mieyer pa. J Pediatr. 2006 Jan;148(1):23-9. doi: 10.1016/j.jpeds.2005.08.075. J Pediatr. 2006. PMID: 16423593 Free PMC article. Clinical Trial.
Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist.
Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE. Lustig RH, et al. J Pediatr. 1999 Aug;135(2 Pt 1):162-8. doi: 10.1016/s0022-3476(99)70017-x. J Pediatr. 1999. PMID: 10431109 Clinical Trial.
A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.
Lustig RH, Greenway F, Velasquez-Mieyer P, Heimburger D, Schumacher D, Smith D, Smith W, Soler N, Warsi G, Berg W, Maloney J, Benedetto J, Zhu W, Hohneker J. Lustig RH, et al. Int J Obes (Lond). 2006 Feb;30(2):331-41. doi: 10.1038/sj.ijo.0803074. Int J Obes (Lond). 2006. PMID: 16158082 Free PMC article. Clinical Trial.
Racial disparity in glucagon-like peptide 1 and inflammation markers among severely obese adolescents.
Velásquez-Mieyer PA, Cowan PA, Pérez-Faustinelli S, Nieto-Martínez R, Villegas-Barreto C, Tolley EA, Lustig RH, Alpert BS. Velásquez-Mieyer PA, et al. Diabetes Care. 2008 Apr;31(4):770-5. doi: 10.2337/dc07-1525. Epub 2008 Jan 9. Diabetes Care. 2008. PMID: 18184905
Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus.
Velásquez-Mieyer PA, Neira CP. Velásquez-Mieyer PA, et al. Expert Opin Pharmacother. 2008 Sep;9(13):2377-82. doi: 10.1517/14656566.9.13.2377. Expert Opin Pharmacother. 2008. PMID: 18710361 Review.
11 results
Jump to page
Feedback